Price (90d)
$82.98Signal Score (90d)
50Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $8.32B | $1.56B | $8.94 |
| 2024 | $8.25B | $479.00M | $2.77 |
| 2023 | $8.20B | $1.35B | $7.79 |
| 2022 | $8.13B | $1.34B | $7.79 |
| 2021 | $8.17B | $1.46B | $8.47 |
Social Signal Score
Earnings
Thu, Nov 5(in 3 months)
Consensus estimate $1.40 per share
Typical surprise +9.6% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Aug 5$2.55 vs $1.90beat
- Tue, May 5$1.48 vs $1.35beat
- Thu, Feb 26$1.57 vs $1.50beat
- Thu, Nov 6$1.50 vs $1.43beat
- Thu, Aug 7$1.69 vs $1.45beat
- Thu, May 8$1.34 vs $1.21beat
Estimates and results for SOLV via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
Project earnings forward and see what return today's price implies.
Seeded from SOLV's reported EPS growth of 1.4% a year over 4 years.
- EPS in 5 years
- $9.58
- Implied price
- $86.23
- Return from $88.59
- -0.5% a year
To earn 15.0% a year on these assumptions you'd need to buy at $42.87 — -51.6% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 5 | 7 | 9 | 11 | 13 |
|---|---|---|---|---|---|
| -8.6% | -20.3% | -14.7% | -10.3% | -6.7% | -3.5% |
| -3.6% | -15.9% | -10.1% | -5.4% | -1.6% | 1.8% |
| 1.4% | -11.6% | -5.4% | -0.5% | 3.5% | 7.1% |
| 6.4% | -7.2% | -0.8% | 4.4% | 8.6% | 12.3% |
| 11.4% | -2.8% | 3.9% | 9.3% | 13.7% | 17.6% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (5)
- Newszacks.com·1d ago·Neutral
SOLV Plans Health Information Systems Business Spinoff to Drive Growth Solventum plans to spin off its $1.4B HIS business, sharpening its MedTech focus while giving HIS more flexibility to pursue growth.
View source ↗ - Newsmarketbeat.com·2d ago·Neutral
SOLV Energy Q2 Earnings Call Highlights SOLV Energy NASDAQ: MWH reported record first-half results for 2026, citing increased new-construction activity, project execution and contributions from prior acquisitions. The company also raised its full-year revenue and adjusted EBITDA outlook while reporting a 44% year-over-year increase in backlog.
View source ↗ - Newsglobenewswire.com·2d ago·Negative
SOLV Energy Reports Second Quarter 2026 Financial Results SAN DIEGO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”) (Nasdaq: MWH), a leading provider of infrastructure services to the power industry, today announced financial results for the second quarter ended June 30, 2026. Financial Summary (in $ millions except percentages) Three Months Ended June 30, Six Months Ended June 30, 2026 2025 2026 2025 Revenue 951 536 1,628 944 Gross Profit 1 140 113 259 1…
View source ↗ - Newszacks.com·5d ago·Positive
Here's Why Solventum (SOLV) is a Strong Momentum Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newsmarketbeat.com·6d ago·Neutral
Solventum Q2 Earnings Call Highlights Solventum NYSE: SOLV reported second-quarter results that exceeded its internal expectations, supported by broad-based segment performance, planned order activity ahead of an ERP cutover and a tariff refund benefit. The company also announced plans to separate its Health Information Systems, or HIS, business as part of a broader effort to sharpen its focus on medical technology markets.
View source ↗